Patatin-like phospholipase domain containing 3: A case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease

Hepatology

Volumn 51, Issue 4, 2010, Pages 1463-1465

  Seth, Devanshi ^a   Daly, Ann K ^b   Haber, Paul S ^c   Day, Christopher P ^b  

^a CENTENARY INSTITUTE   (Australia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONUTRIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MEMBRANE PROTEIN; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3; PHOSPHOLIPASE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DISEASE PREDISPOSITION; ETHNICITY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; LIVER DYSFUNCTION; NONALCOHOLIC FATTY LIVER; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77950625747     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23606     Document Type: Note

References (15)

1. Reed T, Page WF, Viken RJ, Christian JC. Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res 1996;20: 1528-1533.
2. Caetano R, Clark CL. Trends among alcohol related problems among whites, blacks, and Hispanics: 1984-1995. Alcohol Clin Exp Res 1998; 22:534-538.
3. Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res 2001;25:1181-1187.
4. Said A, Williams J, Holden J, Remington P, Musat A, Lucey MR. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting. Clin Gastroenterol Hepatol 2004;2: 928-934.
5. Raynard B, Balian A, Fallick D, Capron F, Bedossa P, Chaput JC, et al. Risk factors of brosis in alcohol-induced liver disease. HEPATO-LOGY 2002;35:635-638.
6. Day CP. From fat to inflammation. Gastroenterology 2006;130:207-210.
7. Browning JD, Kumar KS, Saboorian MH, Theile DL. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol 2004;99: 292-298.
8. Kotronen A, Johansson LE, Johansson IM, Roos C, Westerbacka J, Hamsten A, et al. A common variant in PNPLA3, which encodes adi-ponutrin, is associated with liver fat content in humans. Diabetologia 2009;52:1056-1060.
9. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-1465.
10. Kollerits B, Coassin S, Kiechl S, Hunt SC, Paulweber B, Willeit J, et al. A common variant in the adiponutrin gene influences liver enzyme levels. J Med Genet 2009; doi:10.1136/jmg.2009.066597.
11. Yuan X, Waterworth D, Perry JRB, Lim N, Song K, Chambers JC, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008;83:520-528.
12. Lake AC, Sun Y, Li JL. Expression, regulation, and triglyceride hydrolase activity of adiponutrin family members. J Lipid Res 2005;46:2477-2487.
13. Baulande S, Lasnier F, Lucas M, Pairault J. Adiponutrin, a transmem-brane protein corresponding to a novel dietary-and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 2001; 276:33336-33344.
14. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ. Characterization of the human patatin-like phospholipase family. J Lipid Res 2006;47:1940-1949.
15. Yuan HY, Chiou JJ, Tseng WH, Liu CH, Liu CK, Lin YJ, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006;34:W635-W641.